ACADIA Pharmaceuticals Inc. vs Atmos Energy Corporation — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Atmos Energy Corporation trades at $168.76 (market cap $28.59B). The key difference: Atmos Energy Corporation is far larger — about 5.6× ACADIA Pharmaceuticals Inc.'s market cap, and Atmos Energy Corporation pays a 2.36% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | ATO | |
|---|---|---|
Market Cap | $5.07B | $28.59B |
Sector | Health | Utilities |
52-Week High | $29.41 | $192.25 |
52-Week Low | $20.06 | $162.44 |
Enterprise Value | $4.19B | $38.40B |
Dividend Yield | — | 2.36% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →